About SCIEX
SCIEX is a Healthcare company based in Boston (United States) founded in 1970, and was acquired by Danaher in September 2009. Scientific instrumentation, software, and services for life sciences are provided. SCIEX has completed 1 acquisition, including Intabio. Its website sciex.com draws about 129 thousand monthly visits. Its Indian entity Sciex India Private Limited reported revenue of ₹262 Cr. Its focus areas include Life Sciences, Genomics, Genome Informatics and Integrative Bioinformatics Platforms. Its competitors include Cepheid, Helix and Beckman Coulter; 2 of its 3 listed competitors have raised funding.
Company details
SCIEX was established in 1970 and is headquartered in Boston, United States. Focus is placed on the life science sector, where scientific instrumentation, software, and related services are supplied. Key products encompass mass spectrometers, electrophoresis instruments, and front-end HPLC MS systems. Consumables, reagents, and kits are also distributed to support research and analytical processes in the industry.
Associated legal entities of SCIEX
SCIEX operates through Sciex India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sciex India Private Limited CIN U46596MH2023PTC398885 | Active | 14 Mar 2023 | Mumbai, Maharashtra | ₹262 Cr | 3 | View details |
Funding Insights of SCIEX
- Total Rounds 8
- Last Round Grant — $33,467
- First Round $32,972
(Dec 2014)
- Investors Count 1
All 8 funding rounds of SCIEX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $33,467 | Grant | – | – | |
| Nov 2022 | $33,735 | Grant | – | – | |
| Jan 2022 | $27,302 | Grant | – | – | |
| Nov 2020 | $26,083 | Grant | – | – | |
| Dec 2018 | $34,299 | Grant | – | – | |
| Jan 2017 | $2,721 | Grant | – | – | |
| Oct 2015 | $30,966 | Grant | – | – | |
| Dec 2014 | $32,972 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in SCIEX
SCIEX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Danaher and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Dental equipment and medical instruments are manufactured for therapeutic areas. | 1969 | danaher.com |
Investor details for SCIEX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sciex India Private Limited (SCIEX)
Sciex India Private Limited is the primary company behind SCIEX. The board of Sciex India Private Limited currently have 2 directors; the longest-serving is Ashish Balakrishna Tejam, appointed in 2023. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Balakrishna Tejam DIN 10071030 | Director | 14 Mar 2023 | 3 yrs 7 mo | Sciex India Private Limited |
| Abhay Ghanashyam Phadke DIN 10257201 | Director | 27 Jul 2023 | 3 yrs 3 mo | Sciex India Private Limited |
People of SCIEX
265 people are tracked at SCIEX (72 in leadership, 193 in team).
| Name | Role | Group |
|---|---|---|
Erik Schranz | Senior Director Customer Service | Leadership |
John McNamara | Director, Global Customer Experience And Education | Leadership |
Thomas Gordon | Director Of Manufacturing | Leadership |
Peter Goebel | Director, Open Innovation & Business Development | Leadership |
Joe Fox | President | Leadership |
Chris Apicerno | CFO & Global VP, Finance & IT | Leadership |
Chris Lock | VP, Global R&D | Leadership |
Carli Stoller | VP, Human Resources & Internal Communications | Leadership |
Phil Kilby | Senior Director - Innovation, Business Development & Strategy | Leadership |
Blaine Rehkopf | Global Director, IT Governance & Risk | Leadership |
Chikako Konomi | Commercial Director | Leadership |
Mike Cowhig | VP & General Counsel, SCIEX & Life Sciences Instruments Group | Leadership |
Mi Lee | Sr. Director, Fp&a | Leadership |
Usman Habib | VP, Strategy & Business Development | Leadership |
Micael Morvik | VP, Global Operations | Leadership |
Stefano Caso | Director Business Controlling & Sales Operation | Leadership |
David Ortiz | Senior Director Aftermarket Mgt. | Leadership |
Brenda Newton | VP, Quality Assurance & Regulatory Affairs | Leadership |
Joe Lepore | Global Director | Commercial And Service Training | Leadership |
Angela D. Meggetto | Director, Global Total Rewards | Leadership |
245 more people are available in the full profile.
Complete people profiles for SCIEX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SCIEX
Figures of Sciex India Private Limited, the primary company behind SCIEX, for FY 2025. Revenue was ₹262 Cr (+51% year on year). Net profit was ₹26.79 Cr (10% margin). EBITDA was ₹41.62 Cr (16% margin).
- ₹262 CrRevenue · FY 2025 · +51% YoY
- ₹26.79 CrNet profit · 10% margin
- ₹41.62 CrEBITDA · 16% margin
- ₹325 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Sciex India Private Limited are on its company page.
Detailed financial statements for SCIEX
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SCIEX
SCIEX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Intabio.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Analytical platform for biotherapeutic drug quality characterization is offered. | intabio.com | Sunnyvale, United States | 2015 | Jan 2021 | •••• |
Complete acquisition details for SCIEX
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of SCIEX
SCIEX has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Helix and Beckman Coulter.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| beckman.com | 1935 | Brea, United States | Provider of products for biomedical testing for R&D, diagnostic and commercial applications |
Detailed competitors of SCIEX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SCIEX
The website of SCIEX (sciex.com) receives about 129K visits a month.
- Monthly visits129K
▲ 35.6% vs previous month
Websites whose visitors overlap most with SCIEX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| waters.com | 100% | 416.8K | #124,184 | View details | |
aiinmr.com | aiinmr.com | 100% | #3,358,955 | – | |
| rosesci.com | 100% | #2,331,804 | View details | ||
viscotek.com | viscotek.com | 100% | – | ||
polymersource.com | polymersource.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for SCIEX
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as SCIEX (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sciex
Complete news archive for SCIEX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SCIEX
SCIEX was founded in 1970 and raised its 1st funding round 44 years after it was founded.
SCIEX is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
The primary company behind SCIEX, Sciex India Private Limited, reported revenue of ₹262 Cr for FY 2025, up 51% year on year.
SCIEX was established in 1970 and is headquartered in Boston, United States. Focus is placed on the life science sector, where scientific instrumentation, software, and related services are supplied. Key products encompass mass spectrometers, electrophoresis instruments, and front-end HPLC MS systems. Consumables, reagents, and kits are also distributed to support research and analytical processes in the industry.
SCIEX's top competitors include Cepheid, Helix and Beckman Coulter.
SCIEX has made 1 acquisition, including Intabio.
SCIEX has 2 investors. Key investors include Danaher, and European Union.
SCIEX operates through Sciex India Private Limited.
Yes. SCIEX was acquired by Danaher in September 2009.
The legal entities of SCIEX currently have 3 directors, including Abhay Ghanashyam Phadke, Vishal Jadon, Ashish Balakrishna Tejam.
The website of SCIEX receives about 129 thousand visits a month.